Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection

NCT01157598 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01157598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01157598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection
Lead sponsor
Samsung Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2009
Completion date
Not reported
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric adenoma, gastric cancer